Free release
(8E)-6-Methyl-21,22-dihydro-12-oxa-3,6-diaza-2(6,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-e

(8E)-6-Methyl-21,22-dihydro-12-oxa-3,6-diaza-2(6,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-e

CAS No. :1204918-72-8MDL No. :MFCD22124499Formula :C23H24N4OBoiling Point :-Linear Structure Formula :-InChI Key :-M.W :

Sales:Service@apichina.com
CAS No. :1204918-72-8 Brand :Qitai
Formula :C23H24N4O M.W :372.46

Introduction

CAS No. :1204918-72-8 MDL No. :MFCD22124499
Formula : C23H24N4O Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 372.46 Pubchem ID :-
Synonyms :
SB1317;TG02
Chemical Name :(8E)-6-Methyl-21,22-dihydro-12-oxa-3,6-diaza-2(6,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene

Physicochemical Properties

Num. heavy atoms : 28
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.22
Num. rotatable bonds : 0
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 118.73
TPSA : 53.51 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.4 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.0
Log Po/w (XLOGP3) : 3.06
Log Po/w (WLOGP) : 3.17
Log Po/w (MLOGP) : 2.94
Log Po/w (SILICOS-IT) : 4.05
Consensus Log Po/w : 3.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.55
Solubility : 0.0104 mg/ml ; 0.000028 mol/l
Class : Moderately soluble
Log S (Ali) : -3.85
Solubility : 0.0526 mg/ml ; 0.000141 mol/l
Class : Soluble
Log S (SILICOS-IT) : -7.34
Solubility : 0.0000168 mg/ml ; 0.0000000452 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.86
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: